Anti-GP135/ GPR135/ HUMNPIIY20 monoclonal antibody

Anti-GP135/ GPR135/ HUMNPIIY20 antibody for FACS & in-vivo assay

Target products collectionGo to GPR135/GPR135 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP0507-Ab-1/ GM-Tg-hg-MP0507-Ab-2Anti-Human GPR135 monoclonal antibodyHuman
GM-Tg-rg-MP0507-Ab-1/ GM-Tg-rg-MP0507-Ab-2Anti-Rat GPR135 monoclonal antibodyRat
GM-Tg-mg-MP0507-Ab-1/ GM-Tg-mg-MP0507-Ab-2Anti-Mouse GPR135 monoclonal antibodyMouse
GM-Tg-cynog-MP0507-Ab-1/ GM-Tg-cynog-MP0507-Ab-2Anti-Cynomolgus/ Rhesus macaque GPR135 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP0507-Ab-1/ GM-Tg-felg-MP0507-Ab-2Anti-Feline GPR135 monoclonal antibodyFeline
GM-Tg-cang-MP0507-Ab-1/ GM-Tg-cang-MP0507-Ab-2Anti-Canine GPR135 monoclonal antibodyCanine
GM-Tg-bovg-MP0507-Ab-1/ GM-Tg-bovg-MP0507-Ab-2Anti-Bovine GPR135 monoclonal antibodyBovine
GM-Tg-equg-MP0507-Ab-1/ GM-Tg-equg-MP0507-Ab-2Anti-Equine GPR135 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP0507-Ab-1/ GM-Tg-hg-MP0507-Ab-2; GM-Tg-rg-MP0507-Ab-1/ GM-Tg-rg-MP0507-Ab-2;
GM-Tg-mg-MP0507-Ab-1/ GM-Tg-mg-MP0507-Ab-2; GM-Tg-cynog-MP0507-Ab-1/ GM-Tg-cynog-MP0507-Ab-2;
GM-Tg-felg-MP0507-Ab-1/ GM-Tg-felg-MP0507-Ab-2; GM-Tg-cang-MP0507-Ab-1/ GM-Tg-cang-MP0507-Ab-2;
GM-Tg-bovg-MP0507-Ab-1/ GM-Tg-bovg-MP0507-Ab-2; GM-Tg-equg-MP0507-Ab-1/ GM-Tg-equg-MP0507-Ab-2
Products NameAnti-GPR135 monoclonal antibody
Formatmab
Target NameGPR135
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-GPR135 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species GP135/ GPR135/ HUMNPIIY20 VLP (virus-like particle) (Products Developing)
    ORF Viral VectorpGMLPm004298mouse Gpr135 Lentivirus plasmid
    ORF Viral VectorvGMLPm004298mouse Gpr135 Lentivirus particle


    Target information

    Target IDGM-MP0507
    Target NameGPR135
    Gene ID64582,238252,314213,701843,100856469,101099975,781195,111770288
    Gene Symbol and SynonymsGPR135,HUMNPIIY20,PAFR
    Uniprot AccessionQ8IZ08,Q7TQN7
    Uniprot Entry NameGP135_HUMAN,GP135_RAT
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000181619
    Target ClassificationGPCR

    The target: GPR135, gene name: GPR135, also named as HUMNPIIY20. Enables arrestin family protein binding activity. Predicted to be involved in G protein-coupled receptor signaling pathway. Located in endosome and plasma membrane. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.